Document is current
Any future updates will be listed below
-
Authors
Zhu, Ting-ting
Liu, Pan‑miao
Hashimoto, Kenji https://orcid.org/0000-0002-8892-0439
Yang, Jian-jun https://orcid.org/0000-0001-6785-9627
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82171189)
National Natural Science Foundation of China (81971020)
- License Information
-
More Information
Article History
Received: 6 November 2024
Revised: 10 March 2026
Accepted: 30 March 2026
First Online: 14 April 2026
Competing interest
: Dr. Hashimoto is one of the editorial board members of this journal. Dr. Hashimoto is the inventor of filed patent applications on “The use of R -Ketamine in the treatment of psychiatric diseases”, “( S )-norketamine and salt thereof as pharmaceutical”, “ R -Ketamine and derivative thereof as prophylactic or therapeutic agent for neurodegeneration disease or recognition function disorder”, “Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases”, and “ R -Ketamine and its derivatives as a preventive or therapeutic agent for a neurodevelopmental disorder” by the Chiba University. Dr. Hashimoto has also received research support from Otsuka. The other authors have no conflict of interest.
